Previously, frequent mutation of receptor protein tyrosine phosphatases (PTPRT) has been reported and provided a mechanism for STAT3 hyperactivation in head and neck cancer, so we also detected the mutation of PTPRT in human lung cancer cells, and did not find the same result as in head and neck cancer. This evidence concerns the gene STAT3 and head and neck cancer.